Product NDC: | 51079-051 |
Proprietary Name: | Pantoprazole Sodium |
Non Proprietary Name: | pantoprazole sodium |
Active Ingredient(s): | 40 mg/1 & nbsp; pantoprazole sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51079-051 |
Labeler Name: | Mylan Institutional Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090970 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120905 |
Package NDC: | 51079-051-20 |
Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-051-20) > 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (51079-051-01) |
NDC Code | 51079-051-20 |
Proprietary Name | Pantoprazole Sodium |
Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-051-20) > 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (51079-051-01) |
Product NDC | 51079-051 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | pantoprazole sodium |
Dosage Form Name | TABLET, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20120905 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Institutional Inc. |
Substance Name | PANTOPRAZOLE SODIUM |
Strength Number | 40 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |